查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611805

磺胺类药物市场：按形式、给药途径、分销管道和应用分类 - 2025-2030 年全球预测

Sulphonamides Market by Form (Capsule, Liquid, Powder), Route of Administration (Oral, Topical), Distribution Channel, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年磺胺类药物市值为1.0344亿美元，预计到2024年将达到1.0852亿美元，复合年增长率为5.79%，预计到2030年将达到1.5343亿美元。

磺胺类药物是一种合成抗菌剂，由于其广泛的抗菌特性在製药业中占有重要地位。这种抗菌剂传统上用于治疗细菌感染疾病，其作用原理是抑制细菌中叶酸的合成，降低细菌的繁殖能力。全球细菌感染的持续威胁凸显了对磺胺类药物的需求，特别是在抗生素抗药性高的地区。它的用途不仅限于人类医学，甚至在兽医学中也发挥着重要作用，并可作为化学合成的前体，进一步凸显了其多功能性。最终用途多种多样，包括製药公司、兽医医院和专注于开发新抗菌策略的研究机构。

主要市场统计
基准年[2023] 1.0344亿美元
预测年份 [2024] 10852万美元
预测年份 [2030] 1.5343亿美元
复合年增长率（%） 5.79%

磺胺类药物市场的成长是由感染疾病发病率的增加以及抗菌素抗药性上升对有效抗生素的迫切需求所推动的。由于医疗保健投资的增加和感染疾病的传播，亚洲和非洲的新兴市场尤其带来了巨大的商机。然而，市场面临挑战，包括监管障碍和替代品的威胁，例如副作用较少的新型抗生素。此外，社会对磺胺类药物对环境影响的担忧限制了其广泛使用，磺胺类药物可以透过药物废弃物持续存在于生态系统中。

创新和研究至关重要，可能会在改良磺胺类药物的开发中带来突破，从而在保留疗效的同时最大限度地减少抗药性的产生。此外，标靶递送系统的进步可能会提高治疗指数。磺胺类药物市场的竞争性和动态性以及对解决抗生素抗药性的解决方案的持续需求正在推动对低抗药性风险抗生素的研究投资。公司应重点关注与学术机构的策略合作伙伴关係以进行前沿研究，并与政府卫生机构合作以应对监管环境。最终，市场上的持续成功取决于创新与有效性、安全性和环境友善性的平衡。

市场动态：揭示快速发展的磺胺类药物市场的关键市场洞察

供需的动态交互作用正在改变磺胺类药物市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 世界各地慢性病的盛行率
    • 负担得起的磺胺类药物製剂的大量供应
    • 对磺胺製剂及其治疗用途的认识
  • 市场限制因素
    • 磺胺类药物药物的副作用
  • 市场机会
    • 製药公司加强研发力度
    • 医疗旅游产业快速发展
  • 市场挑战
    • 新兴国家缺乏管理体制

波特的五力磺胺类药物市场策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解磺胺类药物市场的外部影响

外部宏观环境因素在塑造磺胺类药物市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解磺胺类药物市场的竞争格局

对磺胺类药物市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵磺胺类药物市场供应商绩效评估

FPNV定位矩阵是评估磺胺类药物市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了磺胺类药物市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对磺胺类药物市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的慢性病盛行率正在上升
      • 负担得起的磺胺类药物製剂的充足供应
      • 对磺胺类药物及其治疗用途的认识
    • 抑制因素
      • 磺胺类药物药物的副作用
    • 机会
      • 製药公司加强研发力度
      • 医疗旅游产业快速发展
    • 任务
      • 新兴经济体缺乏法律规范
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章磺胺类药物市场：依形式

  • 胶囊
  • 液体
  • 粉末
  • 药片

第七章磺胺类药物市场：依给药途径分类

  • 口服
  • 话题

第八章磺胺类药物市场：依分销管道分类

  • 网路商店零售商
  • 商店型零售商

第九章磺胺类药物市场：依应用分类

  • 胃肠道感染疾病
  • 呼吸道感染疾病
  • 皮肤感染疾病
  • 尿道感染

第十章 美洲磺胺类药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太磺胺类药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲磺胺类药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AA Pharma Inc.
  • Abbott Laboratories
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Cadila Pharmaceuticals Ltd.
  • Cipla Ltd.
  • F. Hoffmann La Roche Ltd.
  • Fera Science Limited
  • GlaxoSmithKline PLC
  • NorthStar Rx LLC
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
Product Code: MRR-62667ADF9D72

The Sulphonamides Market was valued at USD 103.44 million in 2023, expected to reach USD 108.52 million in 2024, and is projected to grow at a CAGR of 5.79%, to USD 153.43 million by 2030.

Sulphonamides, a class of synthetic antimicrobial agents, occupy a significant niche in the pharmaceutical industry due to their broad-spectrum antibacterial properties. Traditionally used to treat bacterial infections, they operate by inhibiting folic acid synthesis in bacteria, impairing their ability to multiply. The necessity of sulphonamides is underscored by the persistent threat of bacterial infections globally, particularly in regions with high antibiotic resistance. Their application extends beyond human medicine, finding roles in veterinary medicine and even as precursors in chemical synthesis-further underscoring their versatile nature. End-use scope is broad, covering pharmaceutical companies, veterinary clinics, and research institutions focused on developing new antibacterial strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 103.44 million
Estimated Year [2024] USD 108.52 million
Forecast Year [2030] USD 153.43 million
CAGR (%) 5.79%

Market growth for sulphonamides is driven by rising incidences of infectious diseases and the urgent need for effective antibiotics amid growing antimicrobial resistance. In particular, emerging markets in Asia and Africa present significant opportunities due to increasing healthcare investments and prevalence of infectious diseases. However, the market faces challenges such as regulatory hurdles and the threat of substitute drugs like newer antibiotic classes with fewer side effects. Additionally, public concern over the environmental impact of sulphonamides, which can persist in ecosystems through pharmaceutical waste, poses a constraint on their widespread use.

Innovation and research are pivotal, with potential breakthroughs in developing modified sulphonamides that retain efficacy while minimizing resistance development. Moreover, advances in targeted delivery systems could enhance their therapeutic index. The nature of the sulphonamide market is competitive yet dynamic, with ongoing need for solutions addressing antibiotic resistance-a call to action for investment in research toward low-resistance risk antibiotics. Companies should focus on strategic collaborations with academic institutions for cutting-edge research and partner with government health agencies to navigate regulatory landscapes. Ultimately, sustained market success hinges on balancing innovation with efficacy, safety, and environmental considerations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Sulphonamides Market

The Sulphonamides Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases worldwide
    • Substantial availability of affordable sulfonamide drug formulations
    • Awareness regarding sulpha drugs and its therapeutic uses
  • Market Restraints
    • Side effects of sulphonamides
  • Market Opportunities
    • Increasing research & development in pharmaceutical companies
    • Rapidly advancing medical tourism industry
  • Market Challenges
    • Lack of regulatory structure in emerging economies

Porter's Five Forces: A Strategic Tool for Navigating the Sulphonamides Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Sulphonamides Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Sulphonamides Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Sulphonamides Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Sulphonamides Market

A detailed market share analysis in the Sulphonamides Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Sulphonamides Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Sulphonamides Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Sulphonamides Market

A strategic analysis of the Sulphonamides Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sulphonamides Market, highlighting leading vendors and their innovative profiles. These include AA Pharma Inc., Abbott Laboratories, AbbVie Inc., Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Cipla Ltd., F. Hoffmann La Roche Ltd., Fera Science Limited, GlaxoSmithKline PLC, NorthStar Rx LLC, Novartis AG, Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Sulphonamides Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Form, market is studied across Capsule, Liquid, Powder, and Tablets.
  • Based on Route of Administration, market is studied across Oral and Topical.
  • Based on Distribution Channel, market is studied across Online-Store Retailers and Store-Based Retailers.
  • Based on Application, market is studied across Gastrointestinal Tract Infection, Respiratory Tract Infection, Skin Infections, and Urinary Tract Infection.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases worldwide
      • 5.1.1.2. Substantial availability of affordable sulfonamide drug formulations
      • 5.1.1.3. Awareness regarding sulpha drugs and its therapeutic uses
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of sulphonamides
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing research & development in pharmaceutical companies
      • 5.1.3.2. Rapidly advancing medical tourism industry
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of regulatory structure in emerging economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Sulphonamides Market, by Form

  • 6.1. Introduction
  • 6.2. Capsule
  • 6.3. Liquid
  • 6.4. Powder
  • 6.5. Tablets

7. Sulphonamides Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Oral
  • 7.3. Topical

8. Sulphonamides Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Online-Store Retailers
  • 8.3. Store-Based Retailers

9. Sulphonamides Market, by Application

  • 9.1. Introduction
  • 9.2. Gastrointestinal Tract Infection
  • 9.3. Respiratory Tract Infection
  • 9.4. Skin Infections
  • 9.5. Urinary Tract Infection

10. Americas Sulphonamides Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Sulphonamides Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Sulphonamides Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AA Pharma Inc.
  • 2. Abbott Laboratories
  • 3. AbbVie Inc.
  • 4. Bausch Health Companies Inc.
  • 5. Cadila Pharmaceuticals Ltd.
  • 6. Cipla Ltd.
  • 7. F. Hoffmann La Roche Ltd.
  • 8. Fera Science Limited
  • 9. GlaxoSmithKline PLC
  • 10. NorthStar Rx LLC
  • 11. Novartis AG
  • 12. Pfizer Inc.
  • 13. Sanofi S.A.
  • 14. Teva Pharmaceutical Industries Ltd.
  • 15. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. SULPHONAMIDES MARKET RESEARCH PROCESS
  • FIGURE 2. SULPHONAMIDES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SULPHONAMIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SULPHONAMIDES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SULPHONAMIDES MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SULPHONAMIDES MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES SULPHONAMIDES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES SULPHONAMIDES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. SULPHONAMIDES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. SULPHONAMIDES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SULPHONAMIDES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SULPHONAMIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SULPHONAMIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SULPHONAMIDES MARKET DYNAMICS
  • TABLE 7. GLOBAL SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SULPHONAMIDES MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SULPHONAMIDES MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SULPHONAMIDES MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SULPHONAMIDES MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SULPHONAMIDES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SULPHONAMIDES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SULPHONAMIDES MARKET SIZE, BY ONLINE-STORE RETAILERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SULPHONAMIDES MARKET SIZE, BY STORE-BASED RETAILERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SULPHONAMIDES MARKET SIZE, BY GASTROINTESTINAL TRACT INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SULPHONAMIDES MARKET SIZE, BY RESPIRATORY TRACT INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SULPHONAMIDES MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SULPHONAMIDES MARKET SIZE, BY URINARY TRACT INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES SULPHONAMIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. SULPHONAMIDES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. SULPHONAMIDES MARKET, FPNV POSITIONING MATRIX, 2023